Skip To Content

Participating in open and frank conversations can be a catalyst for both positive change and a better industry. As we share our perspective you will find:

  • Relevant and timely industry information
  • Medication trends, and their impact
  • Case studies, and the results of their related projects
  • Special-subject on-demand webinars

Articles, blogs and podcasts 

Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.

April 13, 2021 · Medicare Insights Team
Optum continually monitors the average wholesale price (AWP) of the most common medications in Workers’ Compensation Medicare Set-Asides (WCMSAs) to help our clients properly assess their WCMSA exposure and achieve the lowest possible allocations. Read more...
April 08, 2021 · Public Policy & Regulatory Affairs Team
The New York Workers’ Compensation Board (WCB) continues its rule-making and communication efforts related to the Drug Formulary and the implementation of OnBoard and the modernization of processes to care for injured persons in New York. Read more...
April 05, 2021 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
March 31, 2021 · Clinical Team
On March 31, 2021, the ODG Drug Formulary (Appendix A) will change the status of several medications, including, but not limited to, skeletal muscle relaxants (SMR). Read more...
March 25, 2021 · Public Policy & Regulatory Affairs Team
The New York Workers’ Compensation Board (WCB) issued a notice and pending emergency rules alerting payers of how to properly report their Prior Authorization Request (PAR) point of contact(s). Read more...
March 25, 2021
In this episode, the Policy Guys talk about the NY Formulary. Read more...
     Next >>
Page 1 of 17

Subscribe today to receive our latest blogs, articles and more.